{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:29:04Z","timestamp":1791307744835,"version":"4.3.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tri-Service Hospital Research Foundation","award":["TSGH-E110219"],"award-info":[{"award-number":["TSGH-E110219"]}]},{"name":"Tri-Service Hospital Research Foundation","award":["TSGH-B-109-010"],"award-info":[{"award-number":["TSGH-B-109-010"]}]},{"name":"Tri-Service Hospital Research Foundation","award":["TSGH-D-109-050"],"award-info":[{"award-number":["TSGH-D-109-050"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Vitiligo is perceived as an autoimmune skin disease. Previous studies showed conflicting data about vitiligo and pregnancy outcomes. To delineate the associations between vitiligo and the pregnancy outcomes, we used the National Health Insurance Research Database of Taiwan to conduct a retrospective cohort study from January 1, 2000 to December 31, 2015. This study population was composed of 1,096 women with vitiligo and 4,384 women without vitiligo, who were all matched according to age, comorbidity, and index year. Compared with the non-vitiligo controls, women with vitiligo had a higher risk of abortion (aHR 1.158, 95% confidence interval (CI) 1.095\u20131.258, P &lt; .001). Perinatal events, such as preterm delivery, pre-eclampsia\/eclampsia, gestational diabetes mellitus, stillbirth, and intrauterine growth retardation, were not different between both groups (aHR 1.065, 95% CI 0.817\u20131.157, P = .413). To determine if systemic treatment before conception decreases the risk of abortion, we assessed the medical history of pregnant women with vitiligo 1 year before pregnancy. Patients who were treated with oral medications had a lower risk of abortion than those who were not (aHR: 0.675, 95% CI: 0.482\u20130.809, P &lt; .001). Our study indicates that there is a higher risk of abortion in pregnant women with vitiligo and the control of disease activity with systemic treatment before conception could improve pregnancy outcomes.<\/jats:p>","DOI":"10.1371\/journal.pone.0248651","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T17:27:05Z","timestamp":1616434025000},"page":"e0248651","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pregnancy outcomes in women with vitiligo: A Taiwanese nationwide cohort study"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-7757","authenticated-orcid":true,"given":"Chih-Tsung","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4576-9900","authenticated-orcid":true,"given":"Chi-Hsiang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Huei","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3286-0780","authenticated-orcid":true,"given":"Wu-Chien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"pone.0248651.ref001","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo","volume":"16","author":"K Ongenae","year":"2003","journal-title":"Pigment Cell Res"},{"key":"pone.0248651.ref002","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0749.2005.00244.x","article-title":"Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?","volume":"18","author":"S Garbelli","year":"2005","journal-title":"Pigment Cell Res"},{"key":"pone.0248651.ref003","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/jdv.12870","article-title":"Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.","volume":"29","author":"YT Chen","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"pone.0248651.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"M Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"pone.0248651.ref005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000084751","article-title":"Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage","volume":"210","author":"K Ongenae","year":"2005","journal-title":"Dermatology"},{"key":"pone.0248651.ref006","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2005.06456.x","article-title":"Effect of vitiligo on self-reported health-related quality of life","volume":"152","author":"K Ongenae","year":"2005","journal-title":"Br J Dermatol"},{"key":"pone.0248651.ref007","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/bjd.16049","article-title":"The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis","volume":"178","author":"O Osinubi","year":"2018","journal-title":"Br J Dermatol"},{"key":"pone.0248651.ref008","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3349\/ymj.2015.56.3.719","article-title":"Prevalence of vitiligo and associated comorbidities in Korea.","volume":"56","author":"H Lee","year":"2015","journal-title":"Yonsei Med J"},{"key":"pone.0248651.ref009","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13104-015-1177-x","article-title":"Autoimmune diseases and pregnancy: analysis of a series of cases","volume":"8","author":"V Gomes","year":"2015","journal-title":"BMC Res Notes"},{"key":"pone.0248651.ref010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/1471-0528.15970","article-title":"Preterm birth phenotypes in women with autoimmune rheumatic diseases: a population-based cohort study","volume":"127","author":"KD Kolstad","year":"2020","journal-title":"BJOG."},{"key":"pone.0248651.ref011","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-4632.2010.04839.x","article-title":"Pregnancy outcome in women with vitiligo","volume":"50","author":"A Horev","year":"2011","journal-title":"Int J Dermatol"},{"key":"pone.0248651.ref012","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jaad.2018.02.036","article-title":"Pregnancy outcomes in patients with vitiligo: A nationwide population-based cohort study from Korea","volume":"79","author":"KY Park","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"pone.0248651.ref013","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2188\/jea.JE20140076","article-title":"Validation of acute myocardial infarction cases in the national health insurance research database in taiwan","volume":"24","author":"CL Cheng","year":"2014","journal-title":"J Epidemiol"},{"key":"pone.0248651.ref014","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2015.07.075","article-title":"Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan","volume":"201","author":"CL Cheng","year":"2015","journal-title":"Int J Cardiol"},{"key":"pone.0248651.ref015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcrc.2004.09.007","article-title":"A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research","volume":"20","author":"DM Needham","year":"2005","journal-title":"J Crit Care"},{"key":"pone.0248651.ref016","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"A Wankowicz-Kalinska","year":"2003","journal-title":"Lab Invest"},{"key":"pone.0248651.ref017","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2340\/00015555-2080","article-title":"Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: a pivotal role of CD8+ cytotoxic t lymphocytes in vitiligo","volume":"95","author":"L Yang","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"pone.0248651.ref018","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1684\/ejd.2013.2011","article-title":"Characterization of circulating CD8+T cells expressing skin homing and cytotoxic molecules in active non-segmental vitiligo","volume":"23","author":"BX Zhang","year":"2013","journal-title":"Eur J Dermatol"},{"key":"pone.0248651.ref019","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00403-016-1690-3","article-title":"Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo","volume":"308","author":"Y Zhen","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"pone.0248651.ref020","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.4049\/jimmunol.151.9.4562","article-title":"Synthesis of T helper 2-type cytokines at the maternal-fetal interface","volume":"151","author":"H Lin","year":"1993","journal-title":"J Immunol"},{"key":"pone.0248651.ref021","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/2006","article-title":"Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions","volume":"4","author":"MP Piccinni","year":"1998","journal-title":"Nat Med"},{"key":"pone.0248651.ref022","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0015-0282(00)00517-3","article-title":"Evidence of a T(H) 1 type response associated with recurrent miscarriage","volume":"73","author":"C Jenkins","year":"2000","journal-title":"Fertil Steril"},{"key":"pone.0248651.ref023","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/CS20130247","article-title":"Profile of maternal CD4 T-cell effector function during normal pregnancy and in women with a history of recurrent miscarriage","volume":"126","author":"D Lissauer","year":"2014","journal-title":"Clin Sci (Lond)."},{"key":"pone.0248651.ref024","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3899\/jrheum.140583","article-title":"Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the Organization of Teratology Information Specialists Autoimmune Diseases in Pregnancy Project","volume":"42","author":"B Bharti","year":"2015","journal-title":"J Rheumatol"},{"key":"pone.0248651.ref025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.berh.2017.09.011","article-title":"Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome","volume":"31","author":"R Fischer-Betz","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"pone.0248651.ref026","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/120347541201600408","article-title":"Vitiligo and associated autoimmune disease: retrospective review of 300 patients","volume":"16","author":"J Sawicki","year":"2012","journal-title":"J Cutan Med Surg"},{"key":"pone.0248651.ref027","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-2133.2012.11198.x","article-title":"The prevalence of thyroid disease in patients with vitiligo: a systematic review","volume":"167","author":"C Vrijman","year":"2012","journal-title":"Br J Dermatol"},{"key":"pone.0248651.ref028","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1684\/ejd.2012.1656","article-title":"Seven cases of vitiligo complicated by atopic dermatitis: suggestive new spectrum of autoimmune vitiligo","volume":"22","author":"A Tanemura","year":"2012","journal-title":"Eur J Dermatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0248651","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T18:06:37Z","timestamp":1698084397000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0248651"}},"subtitle":[],"editor":[{"given":"Christy","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0248651","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]}}}